Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Barraco

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Cancers|March 1, 2020
Moving the Target on the Optimal Adjuvant Strategy for Resected Pancreatic Cancers: A Systematic Review with Meta-AnalysisAntonio Galvano, Marta Castiglia, Sergio Rizzo, et al.
Scientific Reports|September 27, 2024
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patientsValerio Gristina, Tancredi Didier Bazan Russo, Nadia Barraco, et al.
Cancers|August 25, 2019
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-AnalysisAntonio Galvano, Lorena Incorvaia, Giuseppe Badalamenti, et al.
The Journal of Liquid Biopsy|March 3, 2025
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. "Re-discovering the neglected biosources of the liquid biopsy family"Andrea Gottardo, Valerio Gristina, Alessandro Perez, et al.
Critical Reviews in Oncology/Hematology|February 12, 2022
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaningDaniele Fanale, Alessia Pivetti, Daniela Cancelliere, et al.
Analytical Cellular Pathology (Amsterdam)|October 21, 2015
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?Daniele Fanale, Giuseppe Bronte, Francesco Passiglia, et al.
Therapeutic Advances in Medical Oncology|January 6, 2021
<i>BRCA1/2</i> pathogenic variants in triple-negative <i>versus</i> luminal-like breast cancers: genotype-phenotype correlation in a cohort of 531 patientsLorena Incorvaia, Daniele Fanale, Marco Bono, et al.
Therapeutic Advances in Medical Oncology|October 3, 2022
The diagnostic accuracy of <i>PIK3CA</i> mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysisAntonio Galvano, Luisa Castellana, Valerio Gristina, et al.
Oncology and Therapy|November 28, 2024
A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify<sup>®</sup> Mutation ProfilerFrancesco Pepe, Gianluca Russo, Nadia Barraco, et al.
Cancers|December 11, 2022
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective StudyValerio Gristina, Nadia Barraco, Maria La Mantia, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Cancers|March 1, 2020
Moving the Target on the Optimal Adjuvant Strategy for Resected Pancreatic Cancers: A Systematic Review with Meta-AnalysisAntonio Galvano, Marta Castiglia, Sergio Rizzo, et al.
Scientific Reports|September 27, 2024
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patientsValerio Gristina, Tancredi Didier Bazan Russo, Nadia Barraco, et al.
Cancers|August 25, 2019
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-AnalysisAntonio Galvano, Lorena Incorvaia, Giuseppe Badalamenti, et al.
The Journal of Liquid Biopsy|March 3, 2025
Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. "Re-discovering the neglected biosources of the liquid biopsy family"Andrea Gottardo, Valerio Gristina, Alessandro Perez, et al.
Critical Reviews in Oncology/Hematology|February 12, 2022
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaningDaniele Fanale, Alessia Pivetti, Daniela Cancelliere, et al.
Analytical Cellular Pathology (Amsterdam)|October 21, 2015
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?Daniele Fanale, Giuseppe Bronte, Francesco Passiglia, et al.
Therapeutic Advances in Medical Oncology|January 6, 2021
<i>BRCA1/2</i> pathogenic variants in triple-negative <i>versus</i> luminal-like breast cancers: genotype-phenotype correlation in a cohort of 531 patientsLorena Incorvaia, Daniele Fanale, Marco Bono, et al.
Therapeutic Advances in Medical Oncology|October 3, 2022
The diagnostic accuracy of <i>PIK3CA</i> mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysisAntonio Galvano, Luisa Castellana, Valerio Gristina, et al.
Oncology and Therapy|November 28, 2024
A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify<sup>®</sup> Mutation ProfilerFrancesco Pepe, Gianluca Russo, Nadia Barraco, et al.
Cancers|December 11, 2022
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective StudyValerio Gristina, Nadia Barraco, Maria La Mantia, et al.
Pageof 4